Differentiating Erythromelalgia From Raynaud’s Phenomenon, Complex Regional Pain Syndrome, and Cellulitis
Published on: October 20, 2025
Differentiating Erythromelalgia from Raynaud’s Phenomenon, Complex Regional Pain Syndrome, and Cellulitis featured image
Article author photo

Ciara Brunt

Article reviewer photo

Sanojha Rajhbavan

Doctor of Medicine

Overview

Erythromelalgia is a rare condition that affects the small blood vessels and nerves in the extremities. It is characterised by repeated episodes of burning pain, visible redness and increased warmth in the body.1 During a flare-up, the affected areas may feel so hot that patients describe them as “on fire”. These episodes can last from minutes to hours and are often triggered by heat, exercise, stress, or simply wearing socks and shoes. Cooling the skin by using fans, cool water, or elevation usually provides temporary relief, which is an important clue to the diagnosis.

Delayed recognition of erythromelalgia is partly due to its symptoms resembling those of other conditions that cause red, painful, or warm limbs.

This overlap can make diagnosis challenging and sometimes leads to delays in receiving the correct therapy, allowing symptoms to persist or worsen.1

Epidemiology

Erythromelalgia is officially classified as a rare disorder, with a prevalence of 0.36–1.3 cases per 100,000 people.2

Age of onset

  • Typical onset: Most cases are diagnosed between the ages of 40 and 60, but this may reflect when symptoms become severe enough to prompt investigation
  • Childhood and teenage onset: Primary (inherited) erythromelalgia can start much earlier. Parents may notice their child complaining of burning or “hot” feet after running or playing, especially in warm weather

Gender distribution

Females assigned at birth are affected slightly more often than males assigned at birth, with some studies reporting a female-to-male ratio of up to 2:1.3

Primary vs secondary erythromelalgia

There are two types of erythromelalgia, primary (occurring on its own) and secondary (linked to another condition). Recognising whether erythromelalgia is primary or secondary is important for treatment:

Primary erythromelalgia

  • It can be sporadic (no family history) or familial, caused by genetic mutations, most commonly in the SCN9A sodium channel gene
  • Symptoms often start in childhood or adolescence and are triggered by heat and activity
  • Pain episodes can last for hours and may be severe enough to limit normal activities2

Secondary erythromelalgia

Pathophysiology

The exact mechanism of erythromelalgia is complex and involves both nerve dysfunction and abnormal blood vessel behaviour.

  • Small fibre neuropathy, which is damage or dysfunction of the tiny nerve fibres that control pain and temperature sensation, can cause exaggerated pain responses
  • Microvascular dysregulation, which is the small blood vessels in the skin, may over-dilate, causing increased blood flow, redness and heat
  • Genetic links like Mutations in the SCN9A gene (encoding the sodium channel NaV1.7), which can cause inherited erythromelalgia by making pain nerves overactive1
  • Triggers such as warm environments, exercise, spicy food, alcohol, stress, and even wearing socks or shoes can precipitate attacks
  • Relief, such as cooling the affected area, resting or elevating the limb, can often bring temporary relief, which is an important diagnostic clue

Clinical presentation of erythromelalgia

The hallmark features include:4

  • Redness (erythema): bright red or dusky discolouration of the feet, hands or sometimes the ears and face
  • Heat: the skin feels warm or even hot to the touch during episodes
  • Pain: burning, throbbing or searing pain that can range from mild discomfort to disabling agony
  • Symmetry: usually affects both feet or both hands in a fairly symmetrical pattern
  • Timing: episodes last from minutes to hours, often worse in the evening
  • Triggers: heat, activity or stress make symptoms flare
  • Relief: cooling measures such as fans, cold water, and air conditioning can all help to provide relief

Why is it confused with other conditions

Erythromelalgia causes red, painful, warm limbs; hence, it can be mistaken for other conditions:

Distinguishing between these conditions is crucial because their treatments are very different.

Differentiating features

Raynaud’s phenomenon

  • Typical colour sequence: white (pale) to blue (cyanosis) to red (reactive flushing)
  • Triggers: cold exposure or emotional stress
  • Symptoms: numbness, tingling, or discomfort, but usually not intense burning pain
  • Relief: warming the hands or feet5

Erythromelalgia vs Raynaud’s

  • Erythromelalgia is triggered by heat, not cold
  • Pain is burning and intense
  • Redness is persistent during attacks and associated with warmth

Complex regional pain syndrome (CRPS)

  • Symptoms: Severe pain out of proportion to the injury, swelling, colour changes (red, purple, or blue), temperature changes (hot or cold phases), hair/nail growth changes
  • Distribution: Usually affects one limb (asymmetrical)6

Erythromelalgia vs CRPS

  • Erythromelalgia tends to be symmetrical
  • CRPS often has a clear history of injury or surgery
  • CRPS can present with skin thinning, sweating changes and muscle weakness, which are features less common in erythromelalgia
  • Cooling provides dramatic relief in erythromelalgia but may worsen pain in CRPS

Cellulitis

Erythromelalgia vs cellulitis

  • Cellulitis is almost always unilateral (one side)
  • Systemic symptoms (fever, chills) are common
  • Does not improve with cooling; requires antibiotics7

Management of erythromelalgia

Lifestyle and self-care

  • Avoid overheating: use fans, keep rooms cool
  • Wear open footwear or breathable socks
  • Elevate limbs during attacks
  • Caution: Avoid prolonged ice water immersion to prevent skin damage

Medications

Treating secondary causes

  • Manage underlying myeloproliferative disease (hydroxyurea for thrombocytosis)
  • Address peripheral neuropathy or autoimmune disease

Complications and prognosis

Complications

  • Skin damage from excessive cooling (ulcers, frostbite)1
  • Sleep disturbance and depression from chronic pain
  • Mobility limitations during severe flares

Prognosis

  • It can vary. Some patients achieve good control with medication and lifestyle changes
  • Others may have a chronic, relapsing course requiring long-term pain management

Research and future directions

  • Biologic therapies: targeting nerve sodium channels and inflammatory pathways13
  • Neuromodulation: spinal cord stimulation and sympathetic nerve blocks are being studied for refractory cases14

FAQs

Can erythromelalgia and Raynaud’s happen together?

Yes. Some patients experience both, with cold-triggered Raynaud’s attacks and heat-triggered erythromelalgia flares.

How can I tell cellulitis apart from erythromelalgia?

Cellulitis is usually one-sided, accompanied by fever and responds to antibiotics. Erythromelalgia is typically bilateral, recurrent and improves with cooling.

Is erythromelalgia curable?

There is no cure. 

Summary

Erythromelalgia is a rare condition that causes burning pain, redness and heat in the extremities, usually triggered by warmth and relieved by cooling. It can easily be mistaken for Raynaud’s phenomenon, CRPS, or cellulitis, but several clues help differentiate it:

  • Heat vs cold triggers – erythromelalgia flares with heat, Raynaud’s with cold
  • Symmetry – erythromelalgia is usually bilateral, cellulitis and CRPS are often unilateral
  • Relief with cooling – dramatic in erythromelalgia, not in cellulitis or CRPS
  • Lack of systemic illness – erythromelalgia does not cause fever or raised infection markers

Correct diagnosis enables timely treatment, including lifestyle changes, pain management, and, when appropriate, disease-specific therapies such as aspirin for myeloproliferative disorders or sodium channel blockers for primary disease. 

References 

  1. Caldito EG, Kaul S, Caldito NG, Piette W, Mehta S. Erythromelalgia. Part I: Pathogenesis, clinical features, evaluation, and complications. Journal of the American Academy of Dermatology [Internet]. 2024 [cited 2025 Sep 6]; 90(3):453–62. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0190962223011866.
  2. Mann N, King T, Murphy R. Review of primary and secondary erythromelalgia. Clin Exp Dermatol [Internet]. 2019 [cited 2025 Sep 6]; 44(5):477–82. Available from: https://academic.oup.com/ced/article/44/5/477/6607857
  3. Reed K, Davis M. Incidence of erythromelalgia: a population-based study in Olmsted County, Minnesota. Journal of the European Academy of Dermatology and Venereology [Internet]. 2009 [cited 2025 Sep 6]; 23(1):13–5. Available from: https://onlinelibrary.wiley.com/doi/10.1111/j.1468-3083.2008.02938.x.
  4. Thompson GH, Hahn G, Rang M. Erythromelalgia: Clinical Orthopaedics and Related Research [Internet]. 1979 [cited 2025 Sep 6]; 144:249–54. Available from: http://journals.lww.com/00003086-197910000-00042.
  5. Block JA, Sequeira W. Raynaud’s phenomenon. The Lancet [Internet]. 2001 [cited 2025 Sep 6]; 357(9273):2042–8. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0140673600051187.
  6. Taylor S-S, Noor N, Urits I, Paladini A, Sadhu MS, Gibb C, et al. Correction to: Complex Regional Pain Syndrome: A Comprehensive Review. Pain Ther [Internet]. 2021 [cited 2025 Sep 6]; 10(2):893–4. Available from: https://link.springer.com/10.1007/s40122-021-00291-8.
  7. Hirschmann JV, Raugi GJ. Lower limb cellulitis and its mimics. Journal of the American Academy of Dermatology [Internet]. 2012 [cited 2025 Sep 6]; 67(2):163.e1-163.e12. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0190962212004641.
  8. Hou JL, Onajin O, Gangat N, Davis MDP, Wolanskyj AP. Erythromelalgia in patients with essential thrombocythemia and polycythemia vera. Leukemia & Lymphoma [Internet]. 2017 [cited 2025 Sep 6]; 58(3):715–7. Available from: https://www.tandfonline.com/doi/full/10.1080/10428194.2016.1205740.
  9. Wang Z, Wang H, Lee M, Lin M-Y, Lin Z. A stepwise approach for the management of primary erythromelalgia: A prospective single-arm study. Journal of the American Academy of Dermatology [Internet]. 2022 [cited 2025 Sep 6]; 87(3):698–700. Available from: https://www.sciencedirect.com/science/article/pii/S0190962222006764.
  10. Natkunarajah J, Atherton D, Elmslie F, Mansour S, Mortimer P. Treatment with carbamazepine and gabapentin of a patient with primary erythermalgia (erythromelalgia) identified to have a mutation in the SCN9A gene, encoding a voltage-gated sodium channel. Clinical and Experimental Dermatology [Internet]. 2009 [cited 2025 Sep 6]; 34(8):e640–2. Available from: https://academic.oup.com/ced/article/34/8/e640/6625367.
  11. Davis MDP. Lidocaine Patch for Pain of Erythromelalgia. Arch Dermatol [Internet]. 2002 [cited 2025 Sep 6]; 138(1):17. Available from: http://archderm.jamanetwork.com/article.aspx?doi=10.1001/archderm.138.1.17.
  12. Muhiddin KA, Gallen IW, Harries S, Pearce VR. The use of capsaicin cream in a case of erythromelalgia. Postgraduate Medical Journal [Internet]. 1994 [cited 2025 Sep 6]; 70(829):841–3. Available from: https://academic.oup.com/pmj/article/70/829/841/7042455
  13. Bagal SK, Chapman ML, Marron BE, Prime R, Storer RI, Swain NA. Recent progress in sodium channel modulators for pain. Bioorganic & Medicinal Chemistry Letters [Internet]. 2014 [cited 2025 Sep 6]; 24(16):3690–9. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0960894X14006660.
  14. Zuo L, Yang X. Spinal Cord Stimulation in the Treatment of Pediatric Erythromelalgia. Neuromodulation: Technology at the Neural Interface [Internet]. 2023 [cited 2025 Sep 6]; 26(3):S18. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1094715923000569.
Share

Ciara Brunt

arrow-right